Omega-3 fatty acids: A potential booster for tamoxifen therapy?

Expert Review of Anticancer Therapy

Volumn 11, Issue 8, 2011, Pages 1151-1153

  Bidinotto, Lucas Tadeu ^a   López De Cicco, Ricardo ^a   Russo, Jose ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

adjuvant therapy; breast cancer; omega 3 fatty acids; tamoxifen

Indexed keywords

ANTINEOPLASTIC AGENT; DOCOSAHEXAENOIC ACID; ESTROGEN RECEPTOR ALPHA; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; RALOXIFENE; TAMOXIFEN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RESISTANCE; CELL PROLIFERATION; DIARRHEA; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG RESPONSE; DRUG SELECTIVITY; DRUG SENSITIVITY; FOOD INTAKE; HUMAN; MASTECTOMY; NONHUMAN; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DRUG SYNERGISM; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; TAMOXIFEN;

EID: 80052329733     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/era.11.106     Document Type: Review

References (21)

1. Osborne CK. Tamoxifen in the treatment of breast cancer. N. Engl. J. Med. 339(22), 1609-1618 (1998).
2. Cleator SJ, Ahamed E, Coombes RC, Palmieri C. A 2009 update on the treatment of patients with hormone receptor-positive breast cancer. Clin. Breast Cancer 9(Suppl. 1), S6-S17 (2009).
3. Orlando L, Schiavone P, Fedele P et al. Molecularly targeted endocrine therapies for breast cancer. Cancer Treat. Rev. 36(Suppl. 3), S67-S71 (2010).
4. Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am. J. Clin. Nutr. 54(3), 438-463 (1991).
5. Goyens PL, Spilker ME, Zock PL, Katan MB, Mensink RP. Conversion of a-linolenic acid in humans is influenced by the absolute amounts of a-linolenic acid and linoleic acid in the diet and not by their ratio. Am. J. Clin. Nutr. 84(1), 44-53 (2006).
6. Kang KS, Wang P, Yamabe N, Fukui M, Jay T, Zhu BT. Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One 5(4), e10296 (2010).
7. Barascu A, Besson P, Le Floch O, Bougnoux P, Jourdan ML. CDK1-cyclin B1 mediates the inhibition of proliferation induced by omega-3 fatty acids in MDA-MB-231 breast cancer cells. Int. J. Biochem. Cell Biol. 38(2), 196-208 (2006).
8. Schley PD, Jijon HB, Robinson LE, Field CJ. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res. Treat. 92(2), 187-195 (2005).
9. Truan JS, Chen JM, Thompson LU. Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen. Mol. Nutr. Food Res. 54(10), 1414-1421 (2010).
10. Olivo SE, Hilakivi-Clarke L. Opposing effects of prepubertal low- and high-fat n-3 polyunsaturated fatty acid diets on rat mammary tumorigenesis. Carcinogenesis 26(9), 1563-1572 (2005).
11. Welsch CW. Review of the effects of dietary fat on experimental mammary gland tumorigenesis: Role of lipid peroxidation. Free Radic. Biol. Med. 18(4), 757-773 (1995).
12. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 14(5), 381-395 (2002).
13. Chen J, Hui E, Ip T, Thompson LU. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice. Clin. Cancer Res. 10(22), 7703-7711 (2004).
14. Manni A, Xu H, Washington S et al. The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis. Cancer Prev. Res. 3(3), 322-330 (2010).
15. DeGraffenried LA, Friedrichs WE, Fulcher L et al. Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Ann. Oncol. 14(7), 1051-1056 (2003).
16. Zeitlin L, Segev E, Fried A, Wientroub S. Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice. J. Cell Biochem. 90(2), 347-360 (2003).
17. Coussens LM, Werb Z. Inflammation and cancer. Nature 420(6917), 860-867 (2002).
18. Vanegas JE, Bidinotto LT, Pereira JS et al. Effects of dietary omega-3 and omega-6 in the prevention of rat mammary cancer with tamoxifen. Presented at: American Association for Cancer Research 101th Annual Meeting. Washington, DC, USA, 17-21 April 2010.
19. Bidinotto LT, Vanegas JE, Vanden Heuvel JP et al. Transcriptomic changes in tamoxifen-treated mammary tumors in Sprague-Dawley rats fed with omega-3 or omega-6 rich diets. Presented at: American Association for Cancer Research 102nd Annual Meeting. Orlando, FL, USA, 2-6 April 2011.
20. Shaikh IA, Brown I, Wahle KW, Heys SD. Enhancing cytotoxic therapies for breast and prostate cancers with polyunsaturated fatty acids. Nutr. Cancer 62(3), 284-296 (2010).
21. Baracos VE, Mazurak VC, Ma DW. n-3 polyunsaturated fatty acids throughout the cancer trajectory: Influence on disease incidence, progression, response to therapy and cancer-associated cachexia. Nutr. Res. Rev. 17(2), 177-192 (2004).